FindTrial
Sign In

life expectancy in cervical cancer patients after treatment.

Long term clinical outcomes and toxicity in cervical cancer patients treated with surgery and chemoRadiation-An institutional observational study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/062998
Enrollment
50
Registered
2024-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C538- Malignant neoplasm of overlappingsites of cervix uteri

Interventions

Intervention1: NIL: NIL

Sponsors

J prasanthi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Histopathologically confirmed cervical cancer patients,squamous cell carcinoma or adenocarcinoma, underwent surgery and chemo radiation with curative intent treatment,and having tumors with FIGO stage I or stage II.

Exclusion criteria

Exclusion criteria: Cervical cancer patients treated with palliative intent. Patients previously treated with either surgery or chemo radiation. Patients treated with radical chemoradiation Patients who are not on regular follow up.

Design outcomes

Primary

MeasureTime frame
Overall survivalTimepoint: Overall survival is the period from the date of surgery to date of death—

Secondary

MeasureTime frame
Disease free survivalTimepoint: Disease free survival is the period from the date of surgery to disease recurrence or last follow up.;ToxicityTimepoint: In this trial we are evaluating late toxicity, which occurs after three months of completion of treatment.—

Countries

India

Contacts

Public ContactDinakar kootala

Government medical college,hospital,ananthapuramu.

dinakarkmc1@gmail.com8897444722

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026